You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu


Janssen submits marketing application for talquetamab

The Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen) has announced the submission of a Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA).